CLINICAL_TRIALS
trial_result
· 2012-03-26
Clinical Trial Update: An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer [Phase 3]
Summary
Phase 3 trial comparing vandetanib (ZD6474) to placebo in medullary thyroid carcinoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genzyme, a Sanofi Company | Conditions: Thyroid Cancer | Phase 3 | Status: COMPLETED | Results posted: 2012-03-26